A R T I C L E S
Giordano et al.
more efficient for 2a and 2b than for 3a and 3b. FRET-
augmented cycloreversion accounted for a <20% decrease in
the yield of the closed form upon irradiation with near-UV light.
According to the scheme of Figure 3, the FRET process
contributes to the back reaction via a second parallel pathway
leading to the excited state of the closed form of the dihet-
eroarylethene. The values of Q-+ computed from data obtained
with irradiation at 366 and 340 nm were the same, although at
wavelengths <340 nm, a distinct trend to lower conversion
efficiencies was observed. Under all conditions, the computed
values of Q-+ were <0.5, implying the existence of the two
states postulated for the open form, only one of which can
undergo cyclization. The presumption is that the equilibration
between the open-form conformers is very rapid, leading to a
preequilibrium that is implicit in the scheme of Figure 3.
The quenching of a donor engaged in a FRET process is
generally reflected in a corresponding fractional change (reduc-
tion) of its fluorescence lifetime. We observed two donor species
in the photostationary state after irradiation in the near-UV, for
example, at 366 nm. One of these corresponded to the population
of donor 1 attached to the diheteroarylethene in the closed form,
the latter acting as an efficient energy acceptor and thus
quenching the donor virtually completely. The other fraction
represented 1 bound to the diheteroarylethene in the open form,
characterized by an E- ≈ 0 and thus incapable of generating a
significant FRET effect. This case can be visualized in the time
domain with an expression for the decay of two fluorescence
species excited by a pulse of light:
results of such experiments. Other applications of pcFRET
include the potential for enhancing signal-to-background rela-
tionships in analytical procedures using flow cytometric or
imaging technology, which are characterized by very low levels
of specific complexes.
Experimental Section
Materials. (3-(4-{4-[3,3,4,4,5,5-Hexafluoro-2-(2-methoxy-benzo[b]-
thiophen-3-yl)-cyclopent-1-enyl]-3,5-dimethyl-thiophen-2-yl}-benzoy-
lamino)-propionic acid (2a) was prepared by treatment of acyl chloride
of the diheteroarylethene derived from the formyl derivative10 with
â-alanine in ether-water under alkaline condition. 4-(4-{4-[3,3,4,4,5,5-
Hexafluoro-2-(2-methoxy-benzo[b]thiophen-3-yl)-cyclopent-1-enyl]-
3,5-dimethyl-thiophen-2-yl}-phenyl)-butyric acid (2b) was prepared
from the butanol derivative.11a,b,12-14 The details of the synthetic
procedure will be published elsewhere. Lucifer Yellow cadaverine 1,
N-(5-aminopentyl)-4-amino-3,6-disulfo-1,8-naphthalimide, was from
Molecular Probes (Eugene, Oregon). N,N′-dicyclohexyl-carbodiimide
and N-hydroxysuccinimide were purchased from Fluka Chemie AG,
Buchs, Switzerland. We also refer to substructure 1 as LYC and
substructure 2a or 2b as DAE.
(3-(4-{4-[3,3,4,4,5,5-Hexafluoro-2-(2-methoxy-benzo[b]thiophen-
3-yl)-cyclopent-1-enyl]-3,5-dimethyl-thiophen-2-yl}-benzoylamino)-
propionic acid-2,5-dioxo-pyrrolidin-1-yl Ester (4a). Twenty milli-
grams (0.032 mmol) of 2a reacted with 8 mg (0.039 mmol) of DCC
and 4 mg (0.035 mmol) of N-hydroxysuccinimide in 5 mL of dry
acetonitrile at room temperature for 12 h. The dicyclohexylurea was
filtered, and the N-succinimide active ester 4a (Figure 1) was evaporated
in vacuo.
Disodium-6-amino-2-{5-[3-(4-{4-[3,3,4,4,5,5-hexafluoro-2-(2-meth-
oxy-benzo[b]thiophen-3-yl)-cyclopent-1-enyl]-3,5-dimethyl-thiophen-
2-yl}-benzoylamino)-propionylamino]-pentyl}-1,3-dioxo-2,3-dihydro-
1H-benzo[de]isoquinoline-5,8-disulfonate (3a). Sixteen milligrams of
Lucifer Yellow cadaverine (1, 32 µmol) was dissolved in 30 µL of 0.5
M borate buffer (pH 9.2) and reacted with 32 µmol of 4a dissolved in
200 µL of dry acetonitrile, for 2 h at room temperature. The product
was purified by HPLC using a RP-C18 stationary phase and an elution
solvent CH3CN:triethylammonium acetate (TEAA, 1 M, pH 7.0) 35:
65.
-t/τD+
F(t) ) Fo[(1 - Rps)e-t/τ + Rpse
]
(6)
D-
where Fo is the initial donor fluorescence signal, and τD
)
+
τ
D-(1 - E+)/(1 - E-). For the limit E+ ≈ 1, computed for
both 3a and 3b with the diheteroarylethenes in the closed form,
would be too short to be detected in the frequency-domain
τ
D+
system, regardless of the value of Rps. That is, the fluorescence
decay would be dominated by τD . The quenching of steady-
-
1H NMR (500 MHz, CD3OD): δ 9.05 (1H, H-7 LYC), 8.94 (1H, d,
1.5 Hz, H-5 LYC), 8.91 (1H, s, H-2 LYC), 8.49 (1H, s, NH, LYC),
7.20-8.00 (8H, Ar in DAE), 4.05 (2H, t, J ) 8.5 Hz, NCCCCCH2-
NHCO LYC), 3.72 (2H, m, -CONHCH2CH2CO- DAE), 3.20 (2H,
m, NCH2CCCCNHCO LYC), 2.62 (2H, m, CONHCH2CH2CO DAE),
2.47 (1.5H, s, CH3 DAE), 2.45 (1.5H, s, CH3 DAE), 2.42 (1.5H, s,
CH3 DAE), 2.21 (1.5H, s, CH3 DAE), 2.19 (1.5H, s, CH3 DAE), 1.93
(1.5H, s, CH3- DAE), 1.6-1.8 (6H, CH2 LYC). EM, FABMS,
M-H: 1061.3. Anal. Calcd for C47H38F6N4Na2O10S4: C, 52.03; H, 3.73;
N, 3.79. Found: C, 52.36; H, 3.74; N, 3.81.
1H NMR at the photostationary state by irradiation at 366 nm (500
MHz, CD3OD): δ 9.05 (1H, H-7 LYC), 8.94 (1H, d, 1.5 Hz, H-5 LYC),
8.91 (1H, s, H-2 LYC), 8.49 (1H, s, NH, LYC), 7.17-8.00 (Ar in
DAE), 4.05 (2H, t, J ) 8.5 Hz, NCCCCCH2NHCO LYC), 3.72-3.74
(CONHCH2), 3.20 (NCH2CCCCNHCO LYC), 2.62-2.63 (CH2CH2-
CO DAE), 2.47 (s, CH3 DAE), 2.45 (s, CH3 DAE), 2.42 (s, CH3 DAE),
2.35 (s, CH3-DAECF), 2.21 (s, CH3 DAE), 2.19 (s, CH3 DAE), 2.11
state donor fluorescence FD after photogeneration of the closed
form would have been RpsE+ (eq S4). From NMR measure-
ments, we determined Rps (366 nm) to be 0.33 in 2a and 0.85
in 2b, values which were reflected accurately in the extents of
fluorescence quenching (33 and 85%, respectively), allowing
the determination of the FRET efficiency (100%) for the
diheteroarylethene closed form.
Experiments involving cyclical ring closures and openings
demonstrated that the FRET process can be switched on and
off reversibly. We performed 40 cycles for 3a and 25 cycles
for 3b with no apparent fatigue (Figures 5 and 6). The number
of cycles of FRET activation-deactivation that can be achieved
by cyclic irradiation with UV and visible light is of central
importance, in that this parameter determines the feasibility of
carrying out continuous determinations in dynamic systems, for
example, with living cells.
Recently, we succeeded in conjugating diheteroarylethene-
based photochromic moieties to biomolecules and creating
donor-acceptor pairs via biotin-streptavidin. The donor fluo-
rescence was readily modulated in aqueous solution by cyclic
irradiation.9 The FRET E was 0 for the diheteroarylethene in
the open form and rose to 0.5 with the compound in the closed
form. The formalism for pcFRET presented here provides the
means for developing experimental strategies and analyzing the
(9) Giordano, L.; Macareno, J.; Song, L.; Jovin, T. M.; Irie, M.; Jares-Erijman,
E. Molecules 2000, 5, 591-593.
(10) Takeshita, M.; Irie, M. Chem. Lett. 1998, 1123-1124.
(11) (a) Nakashima, N.; Irie, M. Polym. J. 1998, 30, 985-989. (b) Corey, E. J.;
Schmidt, G. Tetrahedron Lett. 1979, 399-403.
(12) Gadella, T. W. J., Jr.; Jovin, T. M.; Clegg, R. M. Biophys. Chem. 1993,
48, 221-239.
(13) Morgan, C.; Hua, Y.; Mitchell, A.; Murray, J. G.; Boardman, A. ReV. Sci.
Instrum. 1996, 67, 41-47.
(14) Baumann, J.; Calzaferri, G.; Forss, L.; Hugentobler, T. J. J. Photochem.
1985, 28, 457-473.
9
7488 J. AM. CHEM. SOC. VOL. 124, NO. 25, 2002